Papers

1

Total Citations

35

H-Index

1

About

Anant Dinesh is a surgical oncologist whose work centers on refining treatment strategies for head and neck cancers, particularly through minimally invasive techniques. His major contributions lie in evaluating the oncological safety of de-intensified therapy for HPV-negative oropharyngeal cancers, a patient group historically treated with aggressive regimens. His prospective trial on transoral robotic surgery (TORS) for stage I and II HPV-negative disease demonstrated that surgical de-escalation could achieve favorable outcomes while reducing treatment-related morbidity—a critical advance for a population with limited therapeutic alternatives. This landmark study, cited 35 times, has informed clinical guidelines and sparked further investigation into personalized surgical approaches. Dinesh’s work bridges the gap between technological innovation and patient-centered care, offering evidence that robotic surgery can maintain oncological control without the toxicity of chemoradiation. His research continues to shape the paradigm for early-stage oropharyngeal cancer, emphasizing the value of tailored, less invasive interventions in improving both survival and quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial
35 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Rajiv Gandhi Cancer Institute and Research Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago